Hospital Infections in a Cardiovascular Surgery Department between 1997-2003
Infection is one of the most frightening complications of cardiac surgery (CS). In this study, the surveillance data obtained in CS department between 1997-2003 is evaluated, also focusing on hospital infections (HI) regarding systems and the causative agents, so as to create more effective infectio...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Bilimsel Tip Yayinevi
2005-09-01
|
Series: | Flora Infeksiyon Hastalıkları ve Klinik Mikrobiyoloji Dergisi |
Subjects: | |
Online Access: | http://www.floradergisi.org/getFileContent.aspx?op=REDPDF&file_name=2005-10-3-131-138.pdf |
Summary: | Infection is one of the most frightening complications of cardiac surgery (CS). In this study, the surveillance data obtained in CS department between 1997-2003 is evaluated, also focusing on hospital infections (HI) regarding systems and the causative agents, so as to create more effective infection control measures in future. HI rates were 5.6% (40/719) in 1997; however the rates were 7.9% (84/1070), 12.9% (137/1063), 11.9% (111/927), 15.2% (132/866), 11.5% (115/1001) and 14.1% (168/1189) in 1998, 1999, 2000, 2001, 2002 and 2003 respectively. The department had moved into a new location and settled in 1997, with the increasing number of inpatients. As a result, the rate of HI started to rise from 7.9% in the first year to 11.9-15.2% starting from 1999. Surgical site infections (SSI) were observed as 3.8% on the avarage during seven years. Mediastinitis, one of the serious complications of CS, was seen only 0.4% on the avarage. CS units are considered high risk are- as in terms of methicillin resistant Staphylococcus aureus (MRSA) infections. In this department, MRSA infections were the leading one during 2000-2002 with frequencies of 26%, 25% and 29% respectively, dropping to the second row by 17% following Escherichia coli and Klebsiella infections in 2003. This study emphasizes that further epidemiologic interventions are needed to control the SSI and MRSA infections. |
---|---|
ISSN: | 1300-932X 1300-932X |